A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate ...

Shionogi has struck a deal to take full control of its sleep disorder joint venture, agreeing to pay Apnim | Shionogi has ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

When a child can't sleep because of a nagging cough, it can quickly turn into a nightmare. But parents are often stumped about what's the safest and most effective way to treat this common problem. A ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...